[{"address1": "2 Burlington Woods Drive", "address2": "Suite 100", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "781 552 4452", "website": "https://www.bonebiologics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey  Frelick", "age": 58, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 354109, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8401, "open": 0.8439, "dayLow": 0.8101, "dayHigh": 0.864, "regularMarketPreviousClose": 0.8401, "regularMarketOpen": 0.864, "regularMarketDayLow": 0.8101, "regularMarketDayHigh": 0.864, "payoutRatio": 0.0, "beta": 0.931, "forwardPE": -0.3835616, "volume": 27639, "regularMarketVolume": 27639, "averageVolume": 229298, "averageVolume10days": 260450, "averageDailyVolume10Day": 260450, "bid": 0.8084, "ask": 0.8995, "bidSize": 1, "askSize": 1, "marketCap": 2747673, "fiftyTwoWeekLow": 0.708, "fiftyTwoWeekHigh": 4.25, "fiftyDayAverage": 1.00904, "twoHundredDayAverage": 1.37768, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -577455, "profitMargins": 0.0, "floatShares": 3223939, "sharesOutstanding": 3271040, "sharesShort": 130428, "sharesShortPriorMonth": 75614, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0529, "heldPercentInsiders": 0.021259999, "heldPercentInstitutions": 0.021429999, "shortRatio": 0.57, "shortPercentOfFloat": 0.053600002, "impliedSharesOutstanding": 3271040, "bookValue": 1.179, "priceToBook": 0.71246815, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -7324924, "trailingEps": -4.83, "forwardEps": -2.19, "lastSplitFactor": "1:8", "lastSplitDate": 1703030400, "52WeekChange": -0.671875, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 0.84, "targetHighPrice": 16.5, "targetLowPrice": 16.5, "targetMeanPrice": 16.5, "targetMedianPrice": 16.5, "recommendationMean": 0.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 3325131, "totalCashPerShare": 1.017, "totalDebt": 0, "quickRatio": 8.803, "currentRatio": 10.223, "returnOnAssets": -0.69402003, "returnOnEquity": -1.28714, "freeCashflow": -2726891, "operatingCashflow": -4124935, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BBLG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": -0.011905321, "regularMarketPrice": 0.84, "shortName": "Bone Biologics Corp", "longName": "Bone Biologics Corporation", "messageBoardId": "finmb_99330767", "market": "us_market", "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.83, "epsForward": -2.19, "epsCurrentYear": -2.3, "priceEpsCurrentYear": -0.3652174, "fiftyDayAverageChange": -0.16904002, "fiftyDayAverageChangePercent": -0.16752559, "twoHundredDayAverageChange": -0.53768, "twoHundredDayAverageChangePercent": -0.3902793, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "averageAnalystRating": "0.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "corporateActions": [], "postMarketTime": 1741388610, "regularMarketTime": 1741381200, "exchange": "NCM", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "firstTradeDateMilliseconds": 1634131800000, "postMarketChangePercent": -2.39286, "postMarketPrice": 0.8199, "postMarketChange": -0.0201, "regularMarketChange": -0.000100016594, "regularMarketDayRange": "0.8101 - 0.864", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 229298, "fiftyTwoWeekLowChange": 0.13199997, "fiftyTwoWeekLowChangePercent": 0.18644063, "fiftyTwoWeekRange": "0.708 - 4.25", "fiftyTwoWeekHighChange": -3.41, "fiftyTwoWeekHighChangePercent": -0.80235296, "fiftyTwoWeekChangePercent": -67.1875, "dividendDate": 1532390400, "earningsTimestamp": 1740603600, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "displayName": "Bone Biologics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]